Pfizer says COVID-19 pill near 90% effective in final analysis
The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. (photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)ByREUTERSUpdated:
